Overview
Tomohiro Umezu practices in Tokyo, Japan. Mr. Umezu is rated as an Experienced expert by MediFind in the treatment of DICER1 Syndrome. His top areas of expertise are Multiple Myeloma, Leukemia, DICER1 Syndrome, and Chronic Myelogenous Leukemia (CML).
His clinical research consists of co-authoring 51 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 1 article in the study of DICER1 Syndrome.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Myeloid Leukemia (AML)Mr. Umezu isExperienced. Learn about Acute Myeloid Leukemia (AML).
- Chronic Myelogenous Leukemia (CML)Mr. Umezu isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- CirrhosisMr. Umezu isExperienced. Learn about Cirrhosis.
- DICER1 SyndromeMr. Umezu isExperienced. Learn about DICER1 Syndrome.
- HepatitisMr. Umezu isExperienced. Learn about Hepatitis.
- Hepatitis CMr. Umezu isExperienced. Learn about Hepatitis C.